Received Sep 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y017907 | — |
No additional AE; Customer called to report TE. GARDASIL9 was administered to one patient. No additional AE/No PQC ? Names of vaccines involved (including lot/exp) GARDASIL9 Y017907 12/15/2026 ? Temperature 8.42 C ? Time frame for; This spontaneous report was received from a Nurse Practitioner and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 15-Sep-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant Injection (lot #Y017907, expiration date: 15-Dec-2026) 0.5 mL total for prophylaxis. It was reported that the suspect vaccine was underwent temperature excursions of 8.42 C (the time frame was 0 hours 10 minutes 0 seconds) (product storage error). There were previous temperature excursions (not specified). No additional adverse event (AE) was reported (no adverse event).